AC
FRTX

Armistice Capital’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Armistice Capital’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,843
Closed -$5.14M – 93
2018
Q4 		$5.14M Hold
13,843
– – 0.39% 48
2018
Q3 		$5.97M Hold
13,843
– – 0.36% 55
2018
Q2 		$5.01M Buy
13,843
+6,541
+90% +$3.08M 0.33% 61
2018
Q1 		$3.33M Buy
7,302
+953
+15% +$473K 0.26% 54
2017
Q4 		$3.66M Buy
+6,349
New +$4.18M 0.36% 54

Other funds holding FRTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Armistice Capital's FRTX Position: Q1 2019 in Review

Armistice Capital sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2019, closing a stake of 13,843 shares — an estimated $5.14M sold.

Armistice Capital first reported a position in FRTX in Q4 2017 and held it in 5 quarters. The position peaked at $5.97M in Q3 2018. 30 funds tracked by Wall St. Rank hold FRTX as of Q1 2019.

  • Armistice Capital reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Armistice Capital sold 13,843 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $5.14M.
  • Armistice Capital first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
  • Armistice Capital's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $5.97M in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Armistice Capital's 13F filing for Q1 2019, filed 15 May 2019.